News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nexvet Reports Financial Results For First Quarter Of Fiscal Year 2017



11/4/2016 9:13:32 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
DUBLIN, Ireland, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three month period ended September 30, 2016.

Recent highlights include:

* Advanced preparations for pivotal studies of the anti-NGF mAb therapy frunevetmab for cats and a pivotal safety study of the anti-NGF mAb therapy ranevetmab for dogs
* Initiated a pivotal target animal safety study of frunevetmab in October
* Announced publication of two peer-reviewed articles regarding frunevetmab in the Journal of Veterinary Internal Medicine
* Received cash of $1.62 million in research and development income from the Australian Government in October

Read at GlobeNewswire


comments powered by Disqus
Nexvet
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES